ABCB7 and steatosis: Concordantly, histological analyses of livers from HFD-fed LMKO mice revealed a reduction in steatosis (Fig. 4E), a complete rescue of hepatic TG accumulation back to levels measured in NCD-treated mice (Fig. 4D), and a reduction in circulating levels of ALAT by 64% and ASAT by 32% (Fig. 4F).